ASIA-PACIFIC IMMUNOHISTOCHEMISTRY MARKET 2019-2027

MARKET OUTLOOK
The Asia Pacific immunohistochemistry market is projected to develop at a CAGR of 7.36% over the forecast years of 2019-2027.
China, India, Japan, South Korea, ASEAN countries, Australia & New Zealand and countries in rest of APAC have been scrutinized for studying the market on immunohistochemistry in the Asia-pacific region.
The Japan immunohistochemistry market is mainly driven by the rising prevalence of cardiovascular diseases along with the escalating geriatric population in the country. Japan’s continuous declining population is turning into fewer researches. This, along with the lack of enhanced budget for science and technology, implies the country’s global share considering scientific publications is in the stagnant phase. However, the research grants are escalating at top educational institutions with the top five national universities receiving around $900 million of funding.
The South Korean government is inclined towards robots and robotic surgeries. The South Korean government introduced robotic language as the second language in various schools to get accustomed to robots. It is expected that the government in the country will soon offer innovative robots for surgery and other healthcare automation. In the present scenario, one of the most crucial targets of the Australian Immunohistochemistry Society is to provide its members with the best practical teaching materials that would enable them to become effective as pathologists and scientists operating and working in the challenging field of immunochemistry across the globe. The rising prevalence of cancer is fueling the growth of the immunochemistry market in the country.

COMPETITIVE OUTLOOK
The major companies operating in this space are Abbott Laboratories, Abcam Plc, PerkinElmer, Inc., Cell Signaling Technology, Inc., Danaher Corporation, Bio-Rad Laboratories, Inc., Agilent Technologies, Inc., F. Hoffmann-La Roche AG, Histologix, Siemens AG Healthcare, Bio SB, BioGenex, Merck Millipore and Thermo Fisher Scientific, Inc.

TABLE OF CONTENT
1. IMMUNOHISTOCHEMISTRY MARKET - SUMMARY
2. INDUSTRY OUTLOOK
2.1. MARKET DEFINITION
2.2. HISTORY OF IMMUNOHISTOCHEMISTRY
2.3. VALUE CHAIN OUTLOOK
2.4. KEY INSIGHTS
2.5. MARKET ATTRACTIVENESS MATRIX
2.6. MARKET DRIVERS
2.6.1. IN-VITRO TECHNOLOGICAL ADVANCEMENTS
2.6.2. INCREASING CANCER OCCURRENCE
2.6.3. SWELLING HEALTHCARE SPENDING
2.6.4. INCREASING USAGE OF POC TESTING
2.7. MARKET RESTRAINTS
2.7.1. RESTRICTIONS OF CLOSED SYSTEMS
2.7.2. REIMBURSEMENT ISSUES
2.8. MARKET OPPORTUNITIES
2.8.1. INCREASING USAGE OF BIOMARKERS FOR DISEASE DIAGNOSIS
2.8.2. TECHNOLOGICAL ADVANCEMENTS
2.9. MARKET CHALLENGES
2.9.1. HIGH MAINTENANCE COST INFLUENCING THE MARKET GROWTH
3. IMMUNOHISTOCHEMISTRY (IHC) MARKET OUTLOOK - BY PRODUCTS
3.1. ANTIBODIES
3.1.1. PRIMARY ANTIBODIES
3.1.2. SECONDARY ANTIBODIES
3.2. EQUIPMENT
3.2.1. SLIDE STAINING SYSTEMS
3.2.2. TISSUE MICROARRAYS
3.2.3. TISSUE PROCESSING SYSTEMS
3.2.4. SLIDE SCANNERS
3.2.5. OTHER EQUIPMENT
3.3. REAGENTS
3.3.1. HISTOLOGICAL STAINS
3.3.2. BLOCKING SERA AND REAGENTS
3.3.3. CHROMOGENIC SUBSTRATES
3.3.4. FIXATION REAGENTS
3.3.5. STABILIZERS
3.3.6. ORGANIC SOLVENTS
3.3.7. PROTEOLYTIC ENZYMES
3.3.8. DILUENTS
3.4. KITS
4. IMMUNOHISTOCHEMISTRY (IHC) MARKET OUTLOOK - BY APPLICATIONS
4.1. DIAGNOSTICS
4.1.1. CANCER
4.1.2. INFECTIOUS DISEASES
4.1.3. CARDIOVASCULAR DISEASE
4.1.4. AUTOIMMUNE DISEASES
4.1.5. DIABETES MELLITUS
4.1.6. NEPHROLOGICAL DISEASES
4.2. DRUG TESTING
5. IMMUNOHISTOCHEMISTRY (IHC) MARKET OUTLOOK - BY END-USERS
5.1. HOSPITALS AND DIAGNOSTIC LABORATORIES
5.2. RESEARCH INSTITUTES
5.3. OTHER END-USERS
6. IMMUNOHISTOCHEMISTRY (IHC) REGIONAL OUTLOOK - ASIA-PACIFIC
6.1. COUNTRY ANALYSIS
6.1.1. CHINA
6.1.2. INDIA
6.1.3. JAPAN
6.1.4. SOUTH KOREA
6.1.5. AUSTRALIA & NEW ZEALAND
6.1.6. ASEAN COUNTRIES
6.1.7. REST OF APAC
7. COMPETITIVE LANDSCAPE
7.1. ABBOTT LABORATORIES
7.2. ABCAM PLC
7.3. AGILENT TECHNOLOGIES, INC.
7.4. BIOGENEX
7.5. BIO-RAD LABORATORIES, INC.
7.6. BIO SB
7.7. CELL SIGNALING TECHNOLOGY, INC.
7.8. DANAHER CORPORATION
7.9. F. HOFFMANN-LA ROCHE AG
7.10. HISTOLOGIX
7.11. MERCK MILLIPORE
7.12. PERKINELMER, INC.
7.13. SIEMENS AG HEALTHCARE
7.14. THERMO FISHER SCIENTIFIC, INC.
8. METHODOLOGY AND SCOPE
8.1. RESEARCH SCOPE
8.2. SOURCES OF DATA
8.3. RESEARCH METHODOLOGY






TABLE LIST
TABLE 1 ASIA-PACIFIC MARKET FOR IMMUNOHISTOCHEMISTRY 2019-2027 ($ MILLION)
TABLE 2 CANCER MARKERS USED IN DIAGNOSIS AND TREATMENT
TABLE 3 ASIA-PACIFIC IMMUNOHISTOCHEMISTRY MARKET BY PRODUCTS 2019-2027 ($ MILLION)
TABLE 4 ASIA-PACIFIC IMMUNOHISTOCHEMISTRY MARKET IN ANTIBODIES BY TYPE 2019-2027 ($ MILLION)
TABLE 5 CLINICALLY IMPORTANT MONOCLONAL ANTIBODIES
TABLE 6 SECONDARY ANTIBODY SELECTION
TABLE 7 ASIA-PACIFIC IMMUNOHISTOCHEMISTRY MARKET IN EQUIPMENT BY TYPES 2019-2027 ($ MILLION)
TABLE 8 ASIA-PACIFIC IMMUNOHISTOCHEMISTRY MARKET IN REAGENTS BY TYPE 2019-2027 ($ MILLION)
TABLE 9 HISTOLOGY STAINS AND ITS CATEGORIES
TABLE 10 COMMON FIXATIVES AND THEIR GENERAL TARGET ANTIGENS
TABLE 11 ASIA-PACIFIC IMMUNOHISTOCHEMISTRY MARKET IN KITS 2019-2027 ($ MILLION)
TABLE 12 KIT COMPONENTS ARE AVAILABLE FOR IHC OPTIMIZATION
TABLE 13 ASIA-PACIFIC IMMUNOHISTOCHEMISTRY MARKET BY APPLICATION 2019-2027 ($ MILLION)
TABLE 14 ASIA-PACIFIC IMMUNOHISTOCHEMISTRY MARKET IN DIAGNOSTICS BY TYPE 2019-2027 ($ MILLION)
TABLE 15 SELECTED INFECTIOUS ETIOLOGIES OF AUTOIMMUNE DISEASES
TABLE 16 ASIA-PACIFIC IMMUNOHISTOCHEMISTRY MARKET BY END-USERS 2019-2027 ($ MILLION)
TABLE 17 IMMUNOHISTOCHEMISTRY USAGE IN FORENSIC PATHOLOGY
TABLE 18 ASIA-PACIFIC IMMUNOHISTOCHEMISTRY MARKET BY COUNTRY 2019-2027 ($ MILLION)





FIGURES LIST
FIGURE 1 ASIA-PACIFIC MARKET FOR IMMUNOHISTOCHEMISTRY 2019-2027 ($ MILLION)
FIGURE 2 HISTORY OF IMMUNOHISTOCHEMISTRY
FIGURE 3 ASIA-PACIFIC IMMUNOHISTOCHEMISTRY MARKET IN ANTIBODIES 2019-2027 ($ MILLION)
FIGURE 4 ASIA-PACIFIC ANTIBODIES MARKET IN PRIMARY ANTIBODIES 2019-2027 ($ MILLION)
FIGURE 5 ASIA-PACIFIC ANTIBODIES MARKET IN SECONDARY ANTIBODIES 2019-2027 ($ MILLION)
FIGURE 6 ASIA-PACIFIC IMMUNOHISTOCHEMISTRY MARKET IN EQUIPMENT 2019-2027 ($ MILLION)
FIGURE 7 ASIA-PACIFIC EQUIPMENT MARKET IN SLIDE STAINING SYSTEMS 2019-2027 ($ MILLION)
FIGURE 8 ASIA-PACIFIC EQUIPMENT MARKET IN TISSUE MICROARRAYS 2019-2027 ($ MILLION)
FIGURE 9 ASIA-PACIFIC EQUIPMENT MARKET IN TISSUE PROCESSING SYSTEMS 2019-2027 ($ MILLION)
FIGURE 10 ASIA-PACIFIC EQUIPMENT MARKET IN SLIDE SCANNERS 2019-2027 ($ MILLION)
FIGURE 11 ASIA-PACIFIC EQUIPMENT MARKET IN OTHER EQUIPMENT’S 2019-2027 ($ MILLION)
FIGURE 12 ASIA-PACIFIC IMMUNOHISTOCHEMISTRY MARKET IN REAGENTS 2019-2027 ($ MILLION)
FIGURE 13 ASIA-PACIFIC REAGENTS MARKET IN HISTOLOGICAL STAINS 2019-2027 ($ MILLION)
FIGURE 14 ASIA-PACIFIC REAGENTS MARKET IN BLOCKING SERA AND REAGENTS 2019-2027 ($ MILLION)
FIGURE 15 ASIA-PACIFIC REAGENTS MARKET IN CHROMOGENIC SUBSTRATES 2019-2027 ($ MILLION)
FIGURE 16 ASIA-PACIFIC REAGENTS MARKET IN FIXATION REAGENTS 2019-2027 ($ MILLION)
FIGURE 17 ASIA-PACIFIC REAGENTS MARKET IN STABILIZERS 2019-2027 ($ MILLION)
FIGURE 18 ASIA-PACIFIC REAGENTS MARKET IN ORGANIC SOLVENTS 2019-2027 ($ MILLION)
FIGURE 19 ASIA-PACIFIC REAGENTS MARKET IN PROTEOLYTIC ENZYMES 2019-2027 ($ MILLION)
FIGURE 20 ASIA-PACIFIC REAGENTS MARKET IN DILUENTS 2019-2027 ($ MILLION)
FIGURE 21 PHASES OF HISTOLOGICAL STAINING
FIGURE 22 ASIA-PACIFIC IMMUNOHISTOCHEMISTRY MARKET IN KITS 2019-2027 ($ MILLION)
FIGURE 23 ASIA-PACIFIC IMMUNOHISTOCHEMISTRY MARKET IN DIAGNOSTICS 2019-2027 ($ MILLION)
FIGURE 24 ASIA-PACIFIC DIAGNOSTICS MARKET IN CANCER 2019-2027 ($ MILLION)
FIGURE 25 ASIA-PACIFIC DIAGNOSTICS MARKET IN INFECTIOUS DISEASES 2019-2027 ($ MILLION)
FIGURE 26 ASIA-PACIFIC DIAGNOSTICS MARKET IN CARDIOVASCULAR DISEASE 2019-2027 ($ MILLION)
FIGURE 27 ASIA-PACIFIC DIAGNOSTICS MARKET IN AUTOIMMUNE DISEASES 2019-2027 ($ MILLION)
FIGURE 28 ASIA-PACIFIC DIAGNOSTICS MARKET IN DIABETES MELLITUS 2019-2027 ($ MILLION)
FIGURE 29 ASIA-PACIFIC DIAGNOSTICS MARKET IN NEPHROLOGICAL DISEASES 2019-2027 ($ MILLION)
FIGURE 30 ASIA-PACIFIC IMMUNOHISTOCHEMISTRY MARKET IN DRUG TESTING 2019-2027 ($ MILLION)
FIGURE 31 ASIA-PACIFIC IMMUNOHISTOCHEMISTRY MARKET IN HOSPITALS AND DIAGNOSTIC LABORATORIES 2019-2027 ($ MILLION)
FIGURE 32 ASIA-PACIFIC IMMUNOHISTOCHEMISTRY MARKET IN RESEARCH INSTITUTES 2019-2027 ($ MILLION)
FIGURE 33 ASIA-PACIFIC IMMUNOHISTOCHEMISTRY MARKET IN OTHER END-USERS 2019-2027 ($ MILLION)
FIGURE 34 ASIA-PACIFIC IMMUNOHISTOCHEMISTRY MARKET 2019-2027 ($ MILLION)
FIGURE 35 CHINA IMMUNOHISTOCHEMISTRY MARKET 2019-2027 ($ MILLION)
FIGURE 36 INDIA IMMUNOHISTOCHEMISTRY MARKET 2019-2027 ($ MILLION)
FIGURE 37 JAPAN IMMUNOHISTOCHEMISTRY MARKET 2019-2027 ($ MILLION)
FIGURE 38 SOUTH KOREA IMMUNOHISTOCHEMISTRY MARKET 2019-2027 ($ MILLION)
FIGURE 39 AUSTRALIA & NEW ZEALAND IMMUNOHISTOCHEMISTRY MARKET 2019-2027 ($ MILLION)
FIGURE 40 ASEAN COUNTRIES IMMUNOHISTOCHEMISTRY MARKET 2019-2027 ($ MILLION)
FIGURE 41 REST OF APAC IMMUNOHISTOCHEMISTRY MARKET 2019-2027 ($ MILLION)